Kidney Outcomes and the Effect of Proteinuria in Alport Syndrome: A Longitudinal Analysis Using Data From the National Registry of Rare Kidney Diseases (RaDaR)
62nd European Renal Association (ERA) Congress 2025
June 6 - 7, 2025
Austria
Dual Inhibition of the Endothelin and Angiotensin Receptor Ameliorates Renal and Inner Ear Pathologies in Alport Mice
Sparsentan in Pediatric Patients With Rare Proteinuric Kidney Disease: Preliminary Findings From the EPPIK Study